M

Medpace Holdings
D

MEDP

337.20
USD
-4.91
(-1.44%)
مغلق
حجم التداول
12,298
الربح لكل سهم
11
العائد الربحي
-
P/E
30
حجم السوق
10,480,715,857
أصول ذات صلة
    C
    CAH
    -2.540
    (-2.09%)
    118.790 USD
    CNC
    CNC
    -1.260
    (-2.15%)
    57.430 USD
    D
    DVA
    5.950
    (3.85%)
    160.340 USD
    E
    EVH
    -0.280
    (-2.21%)
    12.380 USD
    HCA
    HCA
    -2.41
    (-0.70%)
    342.95 USD
    MCK
    MCK
    -3.56
    (-0.58%)
    606.42 USD
    O
    OMCL
    -0.900
    (-1.93%)
    45.710 USD
    T
    THC
    -7.320
    (-4.50%)
    155.340 USD
    U
    UHS
    0.710
    (0.35%)
    201.710 USD
    المزيد
الأخبار

العنوان: Medpace Holdings

القطاع: Healthcare
الصناعة: Diagnostics & Research
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.